Levin Tablet contains Levocetirizine 5 mg, a potent third-generation non-sedative antihistamine used primarily for the treatment of allergic conditions. Levocetirizine is the active enantiomer of cetirizine and functions as a selective inverse agonist of peripheral histamine H1-receptors, effectively reducing symptoms associated with allergic rhinitis, chronic idiopathic urticaria, and other histamine-mediated allergic disorders. By competitively inhibiting the binding of histamine to H1 receptors, Levin Tablet alleviates symptoms such as nasal congestion, sneezing, rhinorrhea, itchy and watery eyes, and skin hives. The drug is characterized by rapid onset of action and a favorable safety profile, with minimal sedative effects compared to first-generation antihistamines. Levin Tablet is administered orally, typically once daily, with dosage adjustments recommended based on patient age, renal function, and clinical response. It is contraindicated in patients with known hypersensitivity to levocetirizine or any component of the formulation. Caution is advised in patients with severe renal impairment, and concurrent use with other central nervous system depressants should be monitored. Levin Tablet is an effective therapeutic option for managing allergic symptoms, improving patient quality of life through targeted histamine receptor antagonism.